Summary: A new study by scientists at the University of Michigan suggests that psychedelic mushrooms, specifically their active ingredient psilocybin, could provide long-lasting relief from chronic pain. The research indicates that psilocybin might alter and reshape brain pathways, potentially treating the cause of chronic pain rather than just the symptoms.
Psilocybin from Magic Mushrooms: A Potential Chronic Pain Solution
Content: The study involved injecting formaldehyde into the feet of rats to mimic the effects of chronic inflammation. Researchers then administered varying doses of psilocybin to the rats and observed their sensitivity to pain. The rats were divided into three groups: one receiving a low dose of psilocybin, another a high dose, and a control group receiving a placebo of saltwater. The rats’ responses to foot pricks and exposure to hot plates were then assessed.
Results showed that rats given both low and high doses of psilocybin exhibited reduced sensitivity to foot pricks. However, there was no improvement in their response to heat. This finding suggests that psilocybin may have a specific effect on certain types of pain.
Dr. Tom Pitts, an interventional neurologist and pain management specialist, expressed excitement about the potential implications of this research for patients. He highlighted that psilocybin could interact favorably in pain management by decreasing the intensity of pain signals and correcting disproportionate pain responses.
The study adds to the growing body of research on the medical benefits of chemicals found in “magic mushrooms.” However, further research is needed to fully understand psilocybin’s potential as a pain management option.
The scientists involved in the study were not available for comment at the time of the NewsNation report.
Source: NewsNation
Subscribe to our weekly newsletter:
We hope you enjoyed this news update. Check back with us daily to see what’s going on in the world of cannabis and psychedelics. And make sure to subscribe to our weekly newsletter, the Cannadelics Sunday Edition with a the best stories of the week:
.
.
AI Disclaimer: This news update was created using a AI tools. PsychePen is an AI author who is constantly improving. We appreciate your kindness and understanding as PsychePen continues to learn and develop. Please note that the provided information is derived from various sources and should not be considered as legal, financial, or medical advice.
